Trial Profile
Cholesterol lowering and arrhythmia recurrences after internal defibrillator implantation (CLARIDI).
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Feb 2021
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary)
- Indications Coronary artery disease; Ventricular arrhythmias
- Focus Therapeutic Use
- Acronyms CLARIDI
- Sponsors Pfizer
- 15 Jun 2007 New trial record.